Skip to content
lifestyle.d-h.st
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Femasys Inc.
Femasys Regains Compliance with Nasdaq Listing Requirements
June 24, 2026
Femasys Enables OB/GYNs to Deliver First-Line Fertility Treatment with Initial Commercial Use of FemaSeed® Complete
May 16, 2026
Femasys Expands Fertility Care Portfolio in Europe with CE Mark Approval for FemHSG™ Catheter
May 13, 2026
Femasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update
May 11, 2026
Femasys Enables OB/GYNs to Deliver First-Line Fertility Treatment with Initial Commercial Use of FemaSeed® Complete
May 7, 2026
Femasys Launches FemaSeed® Complete for OB/GYNs at ACOG 2026
April 26, 2026
Femasys Launches FemaSeed® Complete for OB/GYNs at ACOG 2026
April 24, 2026
Femasys Advances FemBloc Toward U.S. Approval with Initiation of Pivotal Trial Enrollment
March 10, 2026
←
Previous Page
1
2